181 – 190 of 247
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile
(
- Contribution to journal › Article
- 2006
-
Mark
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia
(
- Contribution to journal › Article
-
Mark
Frequent emergence of resistance in Clostridium difficile during treatment of C-difficile-associated diarrhea with Fusidic acid
(
- Contribution to journal › Article
-
Mark
Demographics of tuberculosis in an emerging EU region in Southern Scandinavia
(
- Contribution to journal › Article
-
Mark
Vaccinia scars associated with better survival for adults. An observational study from Guinea-Bissau
(
- Contribution to journal › Article
-
Mark
Behandling av patienter med hud- och mjukdelsinfektioner. Resultat av STRAMAs diagnos- och receptundersokning bland allmanlakare
(
- Contribution to journal › Article
-
Mark
Tuberculin Reaction, BCG Scar, and Lower Female Mortality.
(
- Contribution to journal › Article
-
Mark
Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa
(
- Contribution to journal › Article
-
Mark
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
(
- Contribution to journal › Article